Filter by: patients
Home > Community Treatment Reports and Side Effects > Methylergonovine Treatment Report
What is Methylergonovine?

Methylergonovine is used in the prevention and treatment of postpartum and postabortion hemorrhage caused by uterine atony or subinvolution.

Reported Purpose & Efficacy

Reasons and Efficacy
Purpose # of patients
# of patients with evaluations Efficacy
Major
Moderate
Slight
None
Can’t tell
Prevent migraine 2 1 Efficacy_moderate
Chronic headaches 2 0
Migraine headaches 1 0

See all 3 patients currently taking Methylergonovine

Mouse over the table for more information

Reported Side Effects

Side effects as an overall problem

Severe
 0
Moderate
 0
Mild
 0
None
 1

Reported Dosages

  0.4 mg daily 0.6 mg daily 1.2 mg daily
  2 Number of Patients: 2 1 Number of Patients: 1 1 Number of Patients: 1  

Reported Stop Reasons

Why Patients Stopped Taking Methylergonovine (multiple reasons could be selected)
Reason # Patients Percentage of patients
Side effects too severe 1   Side effects too severe: 50%
Course of treatment ended 1   Course of treatment ended: 50%

See all 2 patients who’ve stopped taking Methylergonovine

Reported Duration See details about how long patients take this treatment ▼

Stopped Taking Methylergonovine

A bar graph

0-1 month 1-3 months 3-6 months 6 months-1year 1-2 years 2 years or more
0
0
0
0
0

Reported Adherence, Burden & Cost See details from patient evaluations ▼

Adherence

Taking treatment as prescribed

Adherence of Methylergonovine

Always
 1 100%
Usually
 0 0%
Sometimes
 0 0%
Never
 0 0%

Burden

Difficulty being on treatment

Burden of Methylergonovine

Very
 0 0%
Somewhat
 0 0%
A little
 0 0%
Not at all
 1 100%

Cost

Paid out of pocket

Cost of Methylergonovine

$200+
 0 0%
$100-199
 0 0%
$50-99
 0 0%
$25-49
 0 0%
< $25
 0 0%

See more information, including instructions, precautions, side effects, and interactions.

Report created on May 26, 2012.